A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain

Detalhes bibliográficos
Autor(a) principal: Cioato, Stefania Giotti
Data de Publicação: 2022
Outros Autores: Medeiros, Liciane Fernandes, Lopes, Bettega Costa, Medeiros, Helouise Richardt, Caumo, Wolnei, Roesler, Rafael, Torres, Iraci Lucena da Silva
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/250315
Resumo: Introduction: Considering the lack of specific treatments for neuropathic pain, this study aimed to evaluate the effect of a single dose of adenosine A3 receptor IB-MECA on inflammatory and neurotrophic parameters in rats subjected to a neuropathic pain model. Methods: 64 adult male Wistar rats were used. Neuropathic pain was induced by chronic constriction injury (CCI) of the sciatic nerve and the treatment consisted of a 0.5 μmol/kg dose of IB-MECA, a selective A3 adenosine receptor agonist, dissolved in 3% DMSO; vehicle groups received DMSO 3% in saline solution, and morphine groups received 5 mg/kg. Cerebral cortex and hippocampus IL-1β, BDNF, and NGF levels were determined by Enzyme-Linked Immunosorbent assay. Results: The main outcome was that a single dose of IB-MECA was able to modulate the IL-1β hippocampal levels in neuropathic pain induced by CCI and the DMSO increased IL-1β and NGF hippocampal levels in sham-operated rats. However, we did not observe this effect when the DMSO was used as vehicle for IB-MECA, indicating that IB-MECA was able to prevent the effect of DMSO. Conclusions: Considering that the IL-1β role in neuropathic pain and the contributions of the hippocampus are well explored, our result corroborates the relationship between the A3 receptor and the process of chronic pain maintenance.
id UFRGS-2_b88649747b143673c78e11d4ab5873de
oai_identifier_str oai:www.lume.ufrgs.br:10183/250315
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Cioato, Stefania GiottiMedeiros, Liciane FernandesLopes, Bettega CostaMedeiros, Helouise RichardtCaumo, WolneiRoesler, RafaelTorres, Iraci Lucena da Silva2022-10-26T04:47:33Z20222357-9730http://hdl.handle.net/10183/250315001148411Introduction: Considering the lack of specific treatments for neuropathic pain, this study aimed to evaluate the effect of a single dose of adenosine A3 receptor IB-MECA on inflammatory and neurotrophic parameters in rats subjected to a neuropathic pain model. Methods: 64 adult male Wistar rats were used. Neuropathic pain was induced by chronic constriction injury (CCI) of the sciatic nerve and the treatment consisted of a 0.5 μmol/kg dose of IB-MECA, a selective A3 adenosine receptor agonist, dissolved in 3% DMSO; vehicle groups received DMSO 3% in saline solution, and morphine groups received 5 mg/kg. Cerebral cortex and hippocampus IL-1β, BDNF, and NGF levels were determined by Enzyme-Linked Immunosorbent assay. Results: The main outcome was that a single dose of IB-MECA was able to modulate the IL-1β hippocampal levels in neuropathic pain induced by CCI and the DMSO increased IL-1β and NGF hippocampal levels in sham-operated rats. However, we did not observe this effect when the DMSO was used as vehicle for IB-MECA, indicating that IB-MECA was able to prevent the effect of DMSO. Conclusions: Considering that the IL-1β role in neuropathic pain and the contributions of the hippocampus are well explored, our result corroborates the relationship between the A3 receptor and the process of chronic pain maintenance.application/pdfengClinical and biomedical research. Porto Alegre. Vol. 42, no. 2 (2022), p. 128-134Receptor A3 de adenosinaCitocinasDimetil sulfóxidoNeuralgiaFatores de crescimento neuralRatosAdenosine A3 receptorCytokineDMSON6-(3-iodobenzyl) adenosine-5’-methyluronamide (IB-MECA)Neuropathic painNeurotrophinRatsA3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic paininfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001148411.pdf.txt001148411.pdf.txtExtracted Texttext/plain31678http://www.lume.ufrgs.br/bitstream/10183/250315/2/001148411.pdf.txt34c37881b3e26696af3bbc7e4d49f28eMD52ORIGINAL001148411.pdfTexto completo (inglês)application/pdf1213607http://www.lume.ufrgs.br/bitstream/10183/250315/1/001148411.pdfeaaa3c5f1108179ac797024aa32d70fbMD5110183/2503152023-01-14 06:14:46.101938oai:www.lume.ufrgs.br:10183/250315Repositório InstitucionalPUBhttps://lume.ufrgs.br/oai/requestlume@ufrgs.bropendoar:2023-01-14T08:14:46Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
spellingShingle A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
Cioato, Stefania Giotti
Receptor A3 de adenosina
Citocinas
Dimetil sulfóxido
Neuralgia
Fatores de crescimento neural
Ratos
Adenosine A3 receptor
Cytokine
DMSO
N6-(3-iodobenzyl) adenosine-5’-methyluronamide (IB-MECA)
Neuropathic pain
Neurotrophin
Rats
title_short A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title_full A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title_fullStr A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title_full_unstemmed A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
title_sort A3 receptor agonist modulates IL-1β hippocampus levels in a rat model of neuropathic pain
author Cioato, Stefania Giotti
author_facet Cioato, Stefania Giotti
Medeiros, Liciane Fernandes
Lopes, Bettega Costa
Medeiros, Helouise Richardt
Caumo, Wolnei
Roesler, Rafael
Torres, Iraci Lucena da Silva
author_role author
author2 Medeiros, Liciane Fernandes
Lopes, Bettega Costa
Medeiros, Helouise Richardt
Caumo, Wolnei
Roesler, Rafael
Torres, Iraci Lucena da Silva
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cioato, Stefania Giotti
Medeiros, Liciane Fernandes
Lopes, Bettega Costa
Medeiros, Helouise Richardt
Caumo, Wolnei
Roesler, Rafael
Torres, Iraci Lucena da Silva
dc.subject.por.fl_str_mv Receptor A3 de adenosina
Citocinas
Dimetil sulfóxido
Neuralgia
Fatores de crescimento neural
Ratos
topic Receptor A3 de adenosina
Citocinas
Dimetil sulfóxido
Neuralgia
Fatores de crescimento neural
Ratos
Adenosine A3 receptor
Cytokine
DMSO
N6-(3-iodobenzyl) adenosine-5’-methyluronamide (IB-MECA)
Neuropathic pain
Neurotrophin
Rats
dc.subject.eng.fl_str_mv Adenosine A3 receptor
Cytokine
DMSO
N6-(3-iodobenzyl) adenosine-5’-methyluronamide (IB-MECA)
Neuropathic pain
Neurotrophin
Rats
description Introduction: Considering the lack of specific treatments for neuropathic pain, this study aimed to evaluate the effect of a single dose of adenosine A3 receptor IB-MECA on inflammatory and neurotrophic parameters in rats subjected to a neuropathic pain model. Methods: 64 adult male Wistar rats were used. Neuropathic pain was induced by chronic constriction injury (CCI) of the sciatic nerve and the treatment consisted of a 0.5 μmol/kg dose of IB-MECA, a selective A3 adenosine receptor agonist, dissolved in 3% DMSO; vehicle groups received DMSO 3% in saline solution, and morphine groups received 5 mg/kg. Cerebral cortex and hippocampus IL-1β, BDNF, and NGF levels were determined by Enzyme-Linked Immunosorbent assay. Results: The main outcome was that a single dose of IB-MECA was able to modulate the IL-1β hippocampal levels in neuropathic pain induced by CCI and the DMSO increased IL-1β and NGF hippocampal levels in sham-operated rats. However, we did not observe this effect when the DMSO was used as vehicle for IB-MECA, indicating that IB-MECA was able to prevent the effect of DMSO. Conclusions: Considering that the IL-1β role in neuropathic pain and the contributions of the hippocampus are well explored, our result corroborates the relationship between the A3 receptor and the process of chronic pain maintenance.
publishDate 2022
dc.date.accessioned.fl_str_mv 2022-10-26T04:47:33Z
dc.date.issued.fl_str_mv 2022
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/250315
dc.identifier.issn.pt_BR.fl_str_mv 2357-9730
dc.identifier.nrb.pt_BR.fl_str_mv 001148411
identifier_str_mv 2357-9730
001148411
url http://hdl.handle.net/10183/250315
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Clinical and biomedical research. Porto Alegre. Vol. 42, no. 2 (2022), p. 128-134
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/250315/2/001148411.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/250315/1/001148411.pdf
bitstream.checksum.fl_str_mv 34c37881b3e26696af3bbc7e4d49f28e
eaaa3c5f1108179ac797024aa32d70fb
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv lume@ufrgs.br
_version_ 1817725148436889600